Washington’s top pharmaceutical lobby is doing some self-reflection, commissioning a report that looks at its advocacy in the runup to its most consequential legislative loss in decades. Megan R. Wilson talks with Alice Miranda Ollstein about the upcoming report.
Washington’s top pharmaceutical lobby is doing some self-reflection, commissioning a report that looks at its advocacy in the runup to its most consequential legislative loss in decades. Megan R. Wilson talks with Alice Miranda Ollstein about the upcoming report.